| AMAG Announces Financial Results for the First Quarter Ended March 31, 2011 - SunHerald.com |
|
|
SunHerald.com Total Feraheme provider demand 1 and launch incentive program utilization for the first quarter was approximately 19900 grams, nearly all of which was for use in the non-dialysis chronic kidney disease (CKD) setting. In April, the Company responded to |